Dermatologic comorbidities of the patients with severe COVID ‐19: A case‐control study

Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases

(2020) C. Galván Casas et al.   BRITISH JOURNAL OF DERMATOLOGY

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

(2020) Wen Zhang et al.   CLINICAL IMMUNOLOGY

Immunosuppressive and immunomodulator therapy for rare or uncommon skin disorders in pandemic days

(2020) Ayse Serap Karadag et al.   Dermatologic Therapy

A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID ‐19: Will cases of psoriasis increase after COVID ‐19 pandemic?

(2020) Ömer Kutlu et al.   Dermatologic Therapy

Dermatological diseases presented before COVID ‐19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID ‐19?

(2020) Ömer Kutlu et al.   Dermatologic Therapy

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

(2020) Wei-jie Guan et al.   EUROPEAN RESPIRATORY JOURNAL

COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal

(2020) Hasan K. Siddiqi et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Evaluating the efficiency of specimen pooling for PCR‐based detection of COVID‐19

(2020) Supaporn Wacharapluesadee et al.   JOURNAL OF MEDICAL VIROLOGY

Cutaneous small vessel vasculitis secondary to COVID‐19 infection: A case report

(2020) A Mayor‐Ibarguren et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Cutaneous small‐vessel vasculitis associated with novel 2019 coronavirus SARS‐CoV‐2 infection (COVID‐19)

(2020) M. Dominguez‐Santas et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Psoriasis and COVID ‐19: A narrative review with treatment considerations

(2020) Ömer Faruk Elmas et al.   Dermatologic Therapy

COVID‐19 and immunological regulations – from basic and translational aspects to clinical implications

(2020) Michael P. Schön et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

An unusual case of bullous haemorrhagic vasculitis in a COVID‐19 patient

(2020) S. Negrini et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Vasculitis—What Do We Have to Know? A Review of Literature

(2018) Eran Shavit et al.   International Journal of Lower Extremity Wounds

Cytokine storms in infectious diseases

(2017) John R. Teijaro   Seminars in Immunopathology

Molecular pathogenesis of viral hemorrhagic fever

(2017) Christopher F. Basler   Seminars in Immunopathology

TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization

(2017) Olivier Gouin et al.   Protein & Cell

Mortality among severe community-acquired pneumonia patients depends on combinations of 2007 IDSA/ATS minor criteria

(2015) Hai-yan Li et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Th2 Cytokines Augment IL-31/IL-31RA Interactions via STAT6-dependent IL-31RA Expression

(2015) Ramakrishna Edukulla et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Oncostatin M Reduces Lesion Size and Promotes Functional Recovery and Neurite Outgrowth After Spinal Cord Injury

(2014) Helena Slaets et al.   MOLECULAR NEUROBIOLOGY

Cytokines in dermatology - A basic overview

(2011) Arijit Coondoo   INDIAN JOURNAL OF DERMATOLOGY

IL-31 Receptor (IL-31RA) Knockout Mice Exhibit Elevated Responsiveness to Oncostatin M

(2010) J. Bilsborough et al.   JOURNAL OF IMMUNOLOGY

The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome

(2008) Houli Wang et al.   AMERICAN JOURNAL OF EMERGENCY MEDICINE